In the first edition of the series, we spoke with Dr. Antonio Tataranni, Chief Medical Officer of PepsiCo.
Responsible for not only PepsiCo’s global life sciences strategy, but also the R&D Fellows Program and PepsiCo’s COVID-19 efforts, Dr. Tataranni shares his expert insights into the future of Food as Medicine, the ongoing impact of the pandemic, and PepsiCo’s vision in this emerging industry.
Topics covered include:
- What is the biggest limiting factor holding back Food as Medicine from reaching its full potential?
- Is multi-stakeholder collaboration key in advancing this space?
- What is PepsiCo’s vision in this space and what will the next few years hold?